We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Multiplex Cytokine Assays Need Independent Quality Controls

By Biotechdaily staff writers
Posted on 12 Sep 2007
Quality control is particularly important for multiplex cytokine assays due to the greater demands of performing several assays in a single procedure.

Cytokines are signaling proteins, released primarily by immune cells and are implicated in a number of diseases. More...
The complexity of the cytokine signaling network and the roles played by different cytokines is critical to understanding both normal and pathologic processes. There has been an emergence of multiplex assays that give a picture of multiple cytokines in a single sample.

Many cytokine assays suffer from inconsistent accuracy and poor precision. In addition, different manufacturers' assays produce markedly different results depending on the production process and the assay method. Using kit controls can add to the problem. Kit controls are often manufactured using the same materials and production methods as the kit components, then optimized for a specific instrument. They can actually conceal problems arising from the reagents, calibrators, or instruments.

Independent quality controls allow laboratories to validate calibrations, monitor accuracy and precision, and reduce interlaboratory variation. Randox Laboratories (Crumlin, UK) offers tri-level cytokine controls for cytokine assays and high-sensitivity cytokine assays. These controls are suitable for multiplex assays and for multi-center clinical trials.

The Randox controls are 100% human and do not contain preservatives. They are lyophilized and have a two-year shelf life. When reconstituted, they are stable for four hours at +2-8°C or seven days at –20°C. The 12 analytes include seven interleukins (IL-1a, IL-1ß, IL-2, IL-4, IL-6, IL-8, IL-10), epidermal growth factor (EGF), interferon-gamma (IFN-γ), monocyte chemotactic protein-1 (MCP-1), vascular endothelial growth factor (VEGF), and tumor necrosis factor-alpha (TNFa).


Related Links:
Randox Laboratories

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.